Tumor penetrating peptides inhibiting MYC as a potent targeted therapeutic strategy for triple-negative breast cancers

Overexpression of MYC oncogene is highly prevalent in many malignancies such as aggressive triple-negative breast cancers (TNBCs) and it is associated with very poor outcome. Despite decades of research, attempts to effectively inhibit MYC, particularly with small molecules, still remain challenging...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Edina, Sorolla, Anabel, Cunningham, Paula T., Bogdawa, Heique M., Beck, Samuel, Golden, Emily, Dewhurst, Robert E., Florez, Laura, Cruickshank, Mark N., Hoffmann, Katrin, Hopkins, Richard M., Kim, Jonghwan, Woo, Andrew J., Watt, Paul M., Blancafort, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318000/
https://www.ncbi.nlm.nih.gov/pubmed/30076412
http://dx.doi.org/10.1038/s41388-018-0421-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318000/
https://www.ncbi.nlm.nih.gov/pubmed/30076412
http://dx.doi.org/10.1038/s41388-018-0421-y

Ejemplares similares